JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

NeoGenomics Inc

Chiusa

10.63 1.82

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

10.53

Massimo

10.69

Metriche Chiave

By Trading Economics

Entrata

-19M

-45M

Vendite

13M

181M

Margine di Profitto

-24.867

Dipendenti

2,200

EBITDA

-41M

-48M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+6.19% upside

Dividendi

By Dow Jones

Utili prossimi

28 ott 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

537M

1.4B

Apertura precedente

8.81

Chiusura precedente

10.63

Punteggio Tecnico

By Trading Central

Fiducia

Very Strong Bearish Evidence

NeoGenomics Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

24 ott 2025, 16:25 UTC

I principali Market Mover

Obook Shares Rise, Company Secures New Money Transmitter Licenses

23 ott 2025, 12:37 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

Solmate Infrastructure Shares Higher on Acquisition Plans

22 ott 2025, 16:54 UTC

I principali Market Mover

Applied DNA Sciences Shares Rise After Private Investment, Crypto Buys

21 ott 2025, 13:09 UTC

Utili
I principali Market Mover

Galaxy Digital Shares Jump on Swing to 3Q Profit, Surging Revenue

17 ott 2025, 15:03 UTC

I principali Market Mover

Obook Shares Sink Following Public Debut

24 ott 2025, 13:16 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

24 ott 2025, 13:16 UTC

Discorsi di Mercato

Bitcoin Rises After U.S. Inflation Data Firms Rate Cut Bets -- Market Talk

24 ott 2025, 06:59 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

24 ott 2025, 06:59 UTC

Discorsi di Mercato

Bitcoin Rises on Confirmation of Trump-Xi Meeting -- Market Talk

23 ott 2025, 07:04 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

23 ott 2025, 07:04 UTC

Discorsi di Mercato

Bitcoin Edges Higher But U.S.-China Tensions Limit Recovery -- Market Talk

22 ott 2025, 14:05 UTC

Discorsi di Mercato

Bitcoin Could Briefly Fall Below $100K -- Market Talk

22 ott 2025, 09:30 UTC

Acquisizioni, Fusioni, Takeovers

Combination of FalconX, 21Shares to Develop Derivatives, Structured Products -- WSJ

22 ott 2025, 09:30 UTC

Acquisizioni, Fusioni, Takeovers

Crypto Trading Firm FalconX to Buy ETF Manager 21Shares -- WSJ

22 ott 2025, 09:30 UTC

Acquisizioni, Fusioni, Takeovers

FalconX to Fund 21Shares Deal Using Cash, Stock -- WSJ

22 ott 2025, 09:30 UTC

Acquisizioni, Fusioni, Takeovers

FalconX Strikes Deal to Buy Crypto Asset Manager 21Shares -- WSJ

22 ott 2025, 07:57 UTC

Discorsi di Mercato

Bitcoin Falls After Confusing U.S.-China Signals -- Market Talk

21 ott 2025, 10:00 UTC

Acquisizioni, Fusioni, Takeovers

Deal Set to Come Later Tuesday, Executives Say -- WSJ

21 ott 2025, 10:00 UTC

Acquisizioni, Fusioni, Takeovers

Coinbase Strikes Deal for Crypto-Investing Platform Echo -- WSJ

21 ott 2025, 10:00 UTC

Acquisizioni, Fusioni, Takeovers

Coinbase Strikes Roughly $375M Deal for Crypto-Investing Platform Echo, Executives Say -- WSJ

21 ott 2025, 10:00 UTC

Acquisizioni, Fusioni, Takeovers

Coinbase to Fund Deal Using Cash and Stock, Executives Say -- WSJ

21 ott 2025, 08:00 UTC

Discorsi di Mercato

Bitcoin Falls as Recovery Attempts Prove Short-Lived -- Market Talk

20 ott 2025, 14:30 UTC

Acquisizioni, Fusioni, Takeovers

Evernorth to Raise Over $1B in SPAC Deal with Armada II

20 ott 2025, 07:03 UTC

Discorsi di Mercato

Bitcoin Rises on Hopes For De-Escalation in U.S.-China Tensions -- Market Talk

17 ott 2025, 10:37 UTC

Discorsi di Mercato

Bitcoin Extends Losses as Investors Shun Risky Assets -- Market Talk

17 ott 2025, 07:08 UTC

Discorsi di Mercato

Bitcoin Falls as U.S. Regional Bank Concerns, U.S.-China Tensions Weigh -- Market Talk

16 ott 2025, 19:37 UTC

Acquisizioni, Fusioni, Takeovers

Crypto Industry Dives Deeper Into Prediction Markets as Kraken Buys Exchange -- Barrons.com

16 ott 2025, 18:31 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

16 ott 2025, 18:31 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

16 ott 2025, 18:31 UTC

Discorsi di Mercato

Charles Schwab Readies Spot Crypto Trading -- Market Talk

Confronto tra pari

Modifica del prezzo

NeoGenomics Inc Previsione

Obiettivo di Prezzo

By TipRanks

6.19% in crescita

Previsioni per 12 mesi

Media 11.33 USD  6.19%

Alto 14 USD

Basso 8 USD

Basato su 10 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per NeoGenomics Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

10 ratings

5

Acquista

5

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

7.7 / 10.27Supporto e resistenza

A breve termine

Very Strong Bearish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
help-icon Live chat